Michael Geffner
Chief Medical Officer · Immunovant, Inc.
- 2024
- Oct 24, 2025
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Geffner files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew J. Fromkin - $7.96M in IMVT purchases and sales in the last 12 months
- Jay S. Stout - $2.34M in IMVT purchases and sales in the last 12 months
- Melanie Gloria - $1.67M in IMVT purchases and sales in the last 12 months
- Tiago Girao - $1.41M in IMVT purchases and sales in the last 12 months
- Tuyl Christopher van - $1.17M in IMVT purchases and sales in the last 12 months
- Eric Venker - $581K in IMVT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Geffner?
Michael Geffner is a corporate insider, tracked as Chief Medical Officer of Immunovant, Inc. (IMVT). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Michael Geffner last file a Form 4?
The most recent primary Form 4 on record is dated 24 October 2025, one of 5 filings going back to 2024.
Has Michael Geffner been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($228K) across all tracked filings.
